You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

LUVOX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Luvox patents expire, and when can generic versions of Luvox launch?

Luvox is a drug marketed by Ani Pharms, Solvay, and Jazz Pharms. and is included in three NDAs.

The generic ingredient in LUVOX is fluvoxamine maleate. There are eleven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the fluvoxamine maleate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Luvox

A generic version of LUVOX was approved as fluvoxamine maleate by UPSHER SMITH LABS on November 29th, 2000.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for LUVOX?
  • What are the global sales for LUVOX?
  • What is Average Wholesale Price for LUVOX?
Drug patent expirations by year for LUVOX

US Patents and Regulatory Information for LUVOX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms LUVOX fluvoxamine maleate TABLET;ORAL 021519-001 Dec 20, 2007 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-004 Dec 5, 1994 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-001 Dec 5, 1994 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Jazz Pharms LUVOX CR fluvoxamine maleate CAPSULE, EXTENDED RELEASE;ORAL 022033-001 Feb 28, 2008 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for LUVOX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-001 Dec 5, 1994 ⤷  Sign Up ⤷  Sign Up
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-003 Dec 5, 1994 ⤷  Sign Up ⤷  Sign Up
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-004 Dec 5, 1994 ⤷  Sign Up ⤷  Sign Up
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-002 Dec 5, 1994 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for LUVOX

See the table below for patents covering LUVOX around the world.

Country Patent Number Title Estimated Expiration
Argentina 211153 METODO PARA PRODUCIR COMPUESTOS DE ETERES DE O-(AMINOCETIL-N-ALQUIL(C3-C4)-SUSTITUIDO-P-TRIFLOURMETILFENILCETOXIMA. ⤷  Sign Up
Ireland 43768 ⤷  Sign Up
Yugoslavia 39345 ⤷  Sign Up
Belgium 839744 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.